ArticlePharmacology research & perspectives2019

Leucine-rich repeat kinase 2 (LRRK2) inhibitors differentially modulate glutamate release and Serine935 LRRK2 phosphorylation in striatal and cerebrocortical synaptosomes.

Daniela Mercatelli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.